Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Better Cardiorespiratory Fitness Defined as VO2max Increases the Chance of Partial Clinical Remission and Prolongs Remission Duration in People with Newly Diagnosed Type 1 Diabetes.
Flotyńska J, Naskręt D, Niedźwiecki P, Grzelka-Woźniak A, Pypeć A, Kaczmarek A, Cieluch A, Zozulińska-Ziółkiewicz D, Uruska A. Flotyńska J, et al. Among authors: zozulinska ziolkiewicz d. Clin Med Insights Endocrinol Diabetes. 2024 Apr 15;17:11795514241244872. doi: 10.1177/11795514241244872. eCollection 2024. Clin Med Insights Endocrinol Diabetes. 2024. PMID: 38628617 Free PMC article.
Interactive calculator to estimate insulin sensitivity in type 1 diabetes.
Januszewski AS, Niedzwiecki P, Sachithanandan N, Ward GM, O'Neal DN, Zozulinska-Ziolkiewicz DA, Uruska AA, Jenkins AJ. Januszewski AS, et al. Among authors: zozulinska ziolkiewicz da. J Diabetes Investig. 2024 May;15(5):594-597. doi: 10.1111/jdi.14161. Epub 2024 Feb 17. J Diabetes Investig. 2024. PMID: 38366869 Free PMC article.
Controlled attenuation parameter for the assessment of fatty liver in patients with type 1 diabetes mellitus: which cutoffs to choose? Authors' reply.
Grzelka-Woźniak A, Uruska A, Szymańska-Garbacz E, Araszkiewicz A, Jabłkowski M, Czupryniak L, Zozulińska-Ziółkiewicz D. Grzelka-Woźniak A, et al. Among authors: zozulinska ziolkiewicz d. Pol Arch Intern Med. 2024 Jan 29;134(1):16614. doi: 10.20452/pamw.16614. Epub 2024 Jan 29. Pol Arch Intern Med. 2024. PMID: 38284874 Free article. No abstract available.
Lower air ozone concentration is associated with clinical remission in type 1 diabetes diagnosed in adulthood: a prospective, observational study in Wielkopolska region, Poland.
Ciepłucha W, Cieluch A, Jaz K, Flotyńska J, Nowicka A, Ciepłucha A, Zozulińska-Ziółkiewicz D, Uruska A. Ciepłucha W, et al. Among authors: zozulinska ziolkiewicz d. Pol Arch Intern Med. 2024 Jan 29;134(1):16636. doi: 10.20452/pamw.16636. Epub 2024 Jan 2. Pol Arch Intern Med. 2024. PMID: 38164523 Free article.
Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment.
Seekircher L, Tschiderer L, Lind L, Safarova MS, Kavousi M, Ikram MA, Lonn E, Yusuf S, Grobbee DE, Kastelein JJP, Visseren FLJ, Walters M, Dawson J, Higgins P, Agewall S, Catapano A, de Groot E, Espeland MA, Klingenschmid G, Magliano D, Olsen MH, Preiss D, Sander D, Skilton M, Zozulińska-Ziółkiewicz DA, Grooteman MPC, Blankestijn PJ, Kitagawa K, Okazaki S, Manzi MV, Mancusi C, Izzo R, Desvarieux M, Rundek T, Gerstein HC, Bots ML, Sweeting MJ, Lorenz MW, Willeit P. Seekircher L, et al. Among authors: zozulinska ziolkiewicz da. Eur Heart J Open. 2023 Sep 20;3(5):oead089. doi: 10.1093/ehjopen/oead089. eCollection 2023 Sep. Eur Heart J Open. 2023. PMID: 37840587 Free PMC article.
Indirect insulin resistance markers in relation to nonalcoholic fatty liver disease among patients with type 1 diabetes mellitus. Authors' reply.
Grzelka-Woźniak A, Uruska A, Szymańska-Garbacz E, Araszkiewicz A, Jabłkowski M, Czupryniak L, Zozulińska-Ziółkiewicz D. Grzelka-Woźniak A, et al. Among authors: zozulinska ziolkiewicz d. Pol Arch Intern Med. 2023 Aug 30;133(7-8):16553. doi: 10.20452/pamw.16553. Epub 2023 Aug 30. Pol Arch Intern Med. 2023. PMID: 37646594 Free article. No abstract available.
Patient-perceived benefits and risks of off-label use of SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes: a structured qualitative assessment.
Edwards K, Uruska A, Duda-Sobczak A, Zozulinska-Ziolkiewicz D, Lingvay I. Edwards K, et al. Among authors: zozulinska ziolkiewicz d. Ther Adv Endocrinol Metab. 2023 Jun 29;14:20420188231180987. doi: 10.1177/20420188231180987. eCollection 2023. Ther Adv Endocrinol Metab. 2023. PMID: 37440840 Free PMC article.
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease.
Klupa T, Czupryniak L, Dzida G, Fichna P, Jarosz-Chobot P, Gumprecht J, Mysliwiec M, Szadkowska A, Bomba-Opon D, Czajkowski K, Malecki MT, Zozulinska-Ziolkiewicz DA. Klupa T, et al. Among authors: zozulinska ziolkiewicz da. Diabetes Ther. 2023 Aug;14(8):1241-1266. doi: 10.1007/s13300-023-01431-3. Epub 2023 Jun 16. Diabetes Ther. 2023. PMID: 37322319 Free PMC article. Review.
147 results